Regentis Biomaterials (RGNT) Liabilities and Shareholders Equity (2024 - 2025)
Regentis Biomaterials (RGNT) reported Liabilities and Shareholders Equity of $7.6 million for Q4 2025, up 1480.5% year-over-year from $482000.0 in Q4 2024, and up 1480.5% quarter-over-quarter from $482000.0 in Q4 2024.
Regentis Biomaterials (RGNT) Liabilities and Shareholders Equity (2024 - 2025) Analysis & Trends
Regentis Biomaterials (RGNT) has 2 years of Liabilities and Shareholders Equity data on file, last reported at $7.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 20.11 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 50.83 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 39.01 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 8.78 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 4.11 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 14.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 12.48 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 6.31 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 19.85 Bn |
| 10 | Regentis Biomaterials | 3.72 Mn | -3.66 Mn | - | 7.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.62 Mn |
| Dec 31, 2024 | 482,000.00 |